NCT07161791 2025-09-09Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast CancerHarbin Medical UniversityPhase 1/2 Not yet recruiting12 enrolled
NCT05704166 2025-08-08PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer PatientsFujian Medical University Union HospitalPhase 2 Recruiting214 enrolled